Timothy McDermott, MD
Interventional Cardiology · Paducah, KYNPI 1972613487
Payments from drug & device makers
Across 453 payments — averaging $37.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$5K
- Abiomed$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$832
- E.r. Squibb & Sons, L.L.C.$493
- Johnson & Johnson$489
- plus $3K from 31 others
What the payments were for
- Travel & lodging$7,13542%
- Food & beverage$9,84958%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 93 | $4,870 |
| Abbott | 45 | $4,577 |
| Abiomed | 36 | $2,754 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 54 | $832 |
| E.r. Squibb & Sons, L.L.C. | 39 | $493 |
| Johnson & Johnson(2 entities) | 37 | $489 |
| Novartis | 26 | $384 |
| Pfizer | 27 | $353 |
| Boston Scientific | 8 | $290 |
| Philips North America LLC | 6 | $244 |
| Amgen | 14 | $223 |
| Inari Medical, Inc. | 1 | $200 |
| Cvrx, Inc. | 10 | $172 |
| Shockwave Medical, Inc | 5 | $123 |
| Merck | 8 | $119 |
| AstraZeneca | 3 | $105 |
| Intuitive Surgical | 1 | $104 |
| Boehringer Ingelheim | 6 | $81 |
| Actelion Pharmaceuticals US, Inc. | 4 | $75 |
| Cardiovascular Systems Inc. | 4 | $69 |
| Amarin Pharma, Inc. | 4 | $55 |
| Cardinal Health 200 LLC | 2 | $41 |
| Scpharmaceuticals Inc. | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Bayer | 2 | $30 |
| Cardiva Medical, Inc. | 1 | $28 |
| Penumbra, Inc. | 2 | $26 |
| Elutia, Inc. | 2 | $24 |
| AbbVie | 1 | $24 |
| Getinge USA Sales, LLC | 1 | $24 |
| Terumo Medical Corporation | 1 | $22 |
| Acist Medical Systems, Inc. | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Verge Medical, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience V coronary stent system$3,273
- Impella$2,032
- EVERA MRI XT DR SURESCAN$308
- AURORA EV-ICD MRI SURESCAN$289
- Micra$249
- Optis Coronary Imaging System$245
- FLOWTRIEVER CATHETER, S$200
- CT THROMBECTOMY SYSTEM KIT$200
- ANGIOJET$182
- CardioMEMS HF System$141
- AMPLATZER$118
- (9520) IGT Devices Undivided$115
- Da Vinci Surgical System$104
How this compares
$16,993 in reported general payments places this provider in the 60th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $68,191 |
| EntrestoSacubitril/Valsartan | 37 | $32,126 |
| XareltoRivaroxaban | 16 | $21,250 |
| FarxigaDapagliflozin Propanediol | 25 | $17,003 |
| Metoprolol Succinate | 220 | $2,043 |
| ClopidogrelClopidogrel Bisulfate | 118 | $1,056 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 36 | $699 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 78 | $697 |
| Atorvastatin Calcium | 88 | $692 |
| Nitroglycerin | 82 | $576 |
| Amiodarone Hcl | 36 | $484 |
| SotalolSotalol Hcl | 25 | $436 |
| Losartan Potassium | 38 | $405 |
| Metformin Hcl | 25 | $367 |
| Lisinopril | 66 | $356 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $353 | $68,19181 claims |
| NovartisEntresto | $384 | $32,12637 claims |
| Johnson & JohnsonXarelto | $489 | $21,25016 claims |
| AstraZenecaFarxiga | $105 | $17,00325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 129 interventional cardiology providers in Kentucky.
Other interventional cardiology in Paducah
- James FordPaducah$227K
- Shankho GanguliPaducah$56K
- Christopher AdamsPaducah$48K
- Martin RainsPaducah$45K
- Michael FaulknerPaducah$13K
- Thomas TuLouisville$1.4M
- Amit SrivastavaEdgewood$736K
- Avichai EresLexington$616K
- Naresh SolankhiLouisville$545K
- Sreedevi GondiLouisville$535K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.